Skip to content

Effect of Dexmedetomidine Differential Continuous Infusion on Postoperative Delirium in Elderly Patients With Preoperative Non-Sleep Disorders

Effect of Dexmedetomidine Differential Continuous Infusion on Postoperative Delirium in Elderly Patients With Preoperative Non-Sleep Disorders

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400084837
Enrollment
Unknown
Registered
2024-05-27
Start date
2024-05-27
Completion date
Unknown
Last updated
2024-06-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

orthopedics surgery

Interventions

Control group:The same dose of saline was infused continuously
Dexmedetomidine Intervention Group 1:Dexmedetomidine (0.05 ug/kg/h) was infused continuously until 8:00 on 1-day postoperatively.
Dexmedetomidine Intervention Group 2:Dexmedetomidine (0.05 ug/kg/h) was infused continuously until 8:00 on 3-day postoperatively.

Sponsors

The First Affiliated Hospital of Anhui Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1 age =65,2 ASA grade II-III, 3 elective orthopaedic surgery, 4 PQSI score =5, MOCA score =26.

Exclusion criteria

Exclusion criteria: 1 severe sinus bradycardia (HR <50 beats/minute) or II-III degree atrioventricular block; 2 dementia or previous history of stroke; 3 preoperative depression or anxiety; 4 inability to communicate because of language or hearing problems; 5 patients withdrew from the study, 6 patients were transferred to ICU after operation.

Design outcomes

Primary

MeasureTime frame
Incidence of delirium;

Secondary

MeasureTime frame
The severity of delirium;Sleep score;Pain score;Postoperative complications or adverse events;Postoperative hospital stay;

Countries

China

Contacts

Public ContactXinqi Cheng

The First Affiliated Hospital of Anhui Medical University

ch_xqmz@163.com+86 139 6501 5671

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026